
==== Front
Adv TherAdv TherAdvances in Therapy0741-238X1865-8652Springer Healthcare Cheshire 3098028094510.1007/s12325-019-00945-2CorrectionCorrection to: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA Johansen Pierre 1http://orcid.org/0000-0001-5420-279XHunt Barnaby hunt@ossianconsulting.com 2Iyer Neeraj N. 3Dang-Tan Tam 3Pollock Richard F. 21 grid.425956.9Novo Nordisk A/S, Søborg, Denmark 2 Ossian Health Economics and Communications GmbH, Basel, Switzerland 3 grid.452762.0Novo Nordisk Inc, Plainsboro, USA 12 4 2019 12 4 2019 2019 36 5 1200 1200 © The Author(s) 2019Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.issue-copyright-statement© Springer Healthcare Ltd., part of Springer Nature 2019
==== Body
Correction to: Adv Ther 10.1007/s12325-019-00915-8
The article “A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA”, written by Pierre Johansen, Barnaby Hunt, Neeraj N. Iyer, Tam Dang-Tan, Richard F. Pollock was originally published electronically on the publisher’s internet portal (currently SpringerLink) on November 27, 2018 without Open Access.

The article has now been made Open Access. The copyright of the article changed to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and Indicate if changes were made.

The original article has been updated.

